Medications are prescribed to improve patients’ health, not worsen it; however, when medications have dangerous interactions or are taken incorrectly, patients can experience hazardous, eve
At the onset of adopting decentralised clinical trial (DCT) models, sponsors and sites prioritise the integration of electronic clinical outcome assessments (eCOAs) as essential tools.
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.